Over the past decade, IRE1-mediated UPR, the most evolutionarily conserved signaling pathway in ER stress response, has been extensively studied for therapeutic potential in various types of cancers, including MM [13–16]. The gene discussed is ERN1; the disease is Miyoshi myopathy.